Aptevo Therapeutics (APVO) Profit After Tax (2016 - 2022)
Historic Profit After Tax for Aptevo Therapeutics (APVO) over the last 8 years, with Q4 2022 value amounting to -$4.6 million.
- Aptevo Therapeutics' Profit After Tax rose 2963.47% to -$4.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $7.7 million, marking a year-over-year increase of 12612.89%. This contributed to the annual value of -$18.6 million for FY2023, which is 33234.08% down from last year.
- According to the latest figures from Q4 2022, Aptevo Therapeutics' Profit After Tax is -$4.6 million, which was up 2963.47% from -$7.8 million recorded in Q3 2022.
- Over the past 5 years, Aptevo Therapeutics' Profit After Tax peaked at $28.0 million during Q2 2022, and registered a low of -$13.9 million during Q1 2018.
- In the last 5 years, Aptevo Therapeutics' Profit After Tax had a median value of -$7.8 million in 2022 and averaged -$7.2 million.
- In the last 5 years, Aptevo Therapeutics' Profit After Tax plummeted by 13317.4% in 2018 and then soared by 44734.62% in 2022.
- Quarter analysis of 5 years shows Aptevo Therapeutics' Profit After Tax stood at -$12.6 million in 2018, then increased by 12.18% to -$11.0 million in 2019, then soared by 35.0% to -$7.2 million in 2020, then increased by 8.0% to -$6.6 million in 2021, then rose by 29.63% to -$4.6 million in 2022.
- Its Profit After Tax stands at -$4.6 million for Q4 2022, versus -$7.8 million for Q3 2022 and $28.0 million for Q2 2022.